This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Identifying branded drugs with a low likelihood of generic entry has become a crucial strategy for companies looking to expand their product portfolio through in-licensing. Branded drugs, developed through extensive research and clinical trials, often enjoy patent protection for a limited period.
The Future of Generic Drug Development: Opportunities and Challenges for Emerging Markets As the global healthcare landscape continues to evolve, emerging markets are playing an increasingly important role in shaping the future of generic drug development. Share your thoughts in the comments below! Read the full article here: [link]
Why Generic Drugs Matter Generic drugs are the Robin Hoods of the pharmaceutical world, stealing from the rich (brand-name drugs) and giving to the poor (our wallets). They offer the same therapeutic benefits as their brand-name counterparts but at a fraction of the cost. But how do companies develop these cost-effective alternatives?
The French drugmaker will invest 300 million euros into a new entity that will develop lead isotope-based therapies for cancer under the Orano Med brand.
Sanofi has unveiled the global health brand, Impact, to make available standard of care treatments for non-profit supply to at-risk populations in low-income countries. The introduction of the Impact brand is one of the steps adopted since the formation of Sanofi Global Health last year.
The startup, which aims to develop lower-cost alternatives to branded medicines, has licensed two drugs from CStone Pharmaceuticals in a deal that could signal a coming price war in cancer immunotherapy.
One way pharma can take bigger steps in digital Marketing is by developing an internal team of consultants. This team of consultants would ideally be made up of people who not only have expertise in digital marketing but who also can ensure that a brand team’s digital strategy is aligned with online health seekers.
Ensuring you have hired the right one is essential to your brand’s success on both the HCP and consumers’ sides. Many CPG brands are bringing their digital marketing and media buying in-house to reduce costs and ensure that the digital strategies are aligned with key brand insights. How is creative developed?
New technologies have revolutionised brand planning and strategy development, making it easier than ever to create and execute effective brand plans. Explore how these technologies simplify the brand planning process and maximise success.
Brand journalism is a strategic approach that combines the art of storytelling with journalistic principles to create compelling and authentic content that engages and informs the target audience.
The fastest growing beverage brands are those that have tapped into the consumer’s evolving demands, bringing to the table innovative products that combine taste, convenience, affordability and sustainability. Since its founding in 2005, Iconic Brands has been a leader in the development, design and delivery of alcoholic beverages.
Sosei Heptares , a corporate brand of Sosei Group Corporation, has signed a new drug discovery partnership and option-to-license agreement with AbbVie for discovering, developing and marketing new therapies for neurological ailments. On signing of the deal, AbbVie will make an upfront payment of $40m to Sosei Heptares.
Rob’s Backstage Popcorn, a brand launched by the Jonas Brothers and consumer packaged goods (CPG) business The Naked Market, recently raised $7 million in a celebrity-backed series A funding round to support national growth at Albertsons, Kroger, Sam’s Club, Walmart and other retailers.
Risk assessment plays a crucial role in the development of generic drugs, ensuring that these products meet the required standards of safety and efficacy.
The regulatory environment in Japan for generic drug development is complex and has undergone significant changes in recent years. Generic Drug Development To market a generic drug in Japan, an ANDA must be submitted to the PMDA. Conclusion The regulatory environment in Japan for generic drug development is complex and evolving.
Sponsorships can be a powerful way for businesses to connect with their target audience, build relationships with key stakeholders, and promote their brand in a meaningful way. But in order to be truly effective, sponsorships must be aligned with a company’s brand values.
Xeris Biopharma and Horizon Therapeutics have sig n ed a research partnership and option agreement for developing a ready-to-use, highly-concentrated, subcutaneous injection of teprotumumab. Under the deal, Xeris will leverage XeriJect, its technology platform to develop the formulation of teprotumumab.
In 2020, the US Food and Drug Administration (FDA) issued a Guidance for Industry recommending that sponsors include plans for developing age-appropriate formulations of drug products in instances where adult formulations may not be suitable for paediatric patients.
Generic drug development is a complex process that involves not only scientific and medical expertise but also adherence to strict legal and ethical standards. Scientific expertise plays a crucial role in ensuring that generic drugs are held to the same standards of quality, safety, and efficacy as their brand-name counterparts.
It should be because they are a good fit with your brand team and can take your digital marketing to the next level while ensuring that everything they do is best in class. ” More and more pharma companies are becoming reliant on digital agencies to develop and execute their online strategies.
He explains how pharma brand teams and hub program managers can lessen the impact of accumulators and maximizers on patients’ access and adherence. Sam discusses the evolving landscape of copay adjustment programs.
Learn why print remains a preferred channel for healthcare communications, and how printed materials can help build relationships with patients, developbrand loyalty and maintain brand consistency.
It depends on your objectives and an understanding of how physicians are using the web, but your investment directly reflects your brand and company. According to metrics that I have reviewed for several brands, the most critical data for new drugs is the product label for HCPs. Does this mean your HCP website is a waste of money?
The age of social media has proved that people like to share experiences around brands. Enough is enough; please develop a relevant content strategy to help people navigate false and misleading health information. 7even : Every brand team should have an integrated digital marketing person.
Using automation for email campaigns is one of the most efficient methods of communicating with prospective customers and followers who have a genuine interest in following the updates of a business or brand. However, this should not prevent brands from talking to their audience(s).
Before most drugs are launched, much time and effort are spent developing marketing plans and getting approval. There are three essential elements of any good marketing plan: brand objective, Strategy, and tactics. Brand managers usually spend a lot of meetings getting approval for product launches, but that could be a huge mistake.
The advantage is that marketing teams can create online ads without relying on an agency but it requires a digital marketer who fully understands the brand’s target customer. The benefits to developing creative in-house is speed, costs and having someone integrated within the team who really understand the audience.
Ask current patients what drove them to get an Rx for a branded product (MS drug). Most patients said they had done more research online or talked to other patients about their experience before asking their doctor about the brand. The research was straightforward. The results were not what the DTC team expected. Where was DTC ranked?
For every $1 million invested in online banner ads, just 0.1%, or $1,000, derives value for brands, resulting in $999,000 wasted by brands. The question then becomes, “why are pharma brands still using them?” So why is pharma wasting so much money?
However, there is steadily increasing pressure to its market share in China, with several companies developing insulin lispro biosimilars, and alternative lower-priced insulins such as Viatris’ Semglee (insulin glargine). At $92 for a five-pack of injections, Rezvoglar is a 78% discount on the price of Lantus.
Pharma needs to develop digital marketing expertise in-house and have marketing people integrated within each brand team. My recommendation was to review the research used to develop the site, and after two weeks, I’m still waiting for that research. There it was again. That’s unacceptable. It’s elementary.
CPG brands have finally admitted that consumers are changing how they purchase products and brands. Some ignore the trends and believe their brand equity is too strong to be affected, but that’s a huge mistake. 4our: Listening to social media and identifying threats is essential to developing content.
DTC marketers will do a lot of research on brand messaging, but what’s really important is what action your target audience will take due to being exposed to your message. That’s a lot of noise and confusion, so you need to insist that your agency does both usability testing, which includes measuring the brand favorability.
QUICK READ: According to Setup 30% of Brand marketers say they’re likely/somewhat likely to switch Agencies in the next 6 months. Setup also found that one third of brand marketers want their agencies to better understand their business + seek greater transparency and communication between Agency and Brand.
Agencies have experience in leading and developing cutting-edge digital pharma marketing solutions, but they need your help to really be effective. Every effort should be made to integrate them into your brand team fully. Let them leverage their expertise and allow them to really become part of your brand team.
SUMMARY: Pharma has been relying on digital agencies for too long but agencies can’t begin to understand your audience like brand team members. Having a brand digital marketer constantly communicating with digital agencies is a waste of time and money. They need to be part of your brand team so they can understand your audience.
With the latest development, NHS will become the first healthcare system in Europe to offer this drug to prostate cancer patients. It is branded as Nubeqa and is already offered on the NHS for patients with localised prostate cancer. Nearly 9,000 men with prostate cancer will be eligible to receive this treatment.
It sources a wide range of branded or generic equivalent drugs from across the globe to meet the needs of the local market. Lotus Pharmaceuticals CEO Petar Vazharov stated: “We are delighted at our new collaboration with Teraju.
Apple, with its new privacy requirements, is challenging app developers and brands while Facebook cries fowl. First there is the cost of developing an app. But the real question that needs to be answered is, “will an app support brand objectives?” App development is also not just one and done.
You need people who can understand what your brand is trying to do and develop an online strategy that checks all the boxes. They can also help you sort out agency b t from real tactics that are going to drive brand objectives. Today a great MSL team can mean the difference between a successful brand launch and a flop.
“We saw strong operational performance this quarter from key brands such as Paxlovid and Eliquis, particularly in the US, as well as the continued impressive launch of Prevnar 20 for adults in the US. “In
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content